Skip to content

Clinical trials

Nephrotic Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nephrotic Syndrome Country / region: United States Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20041
20081
20095
20103
20111
20123
20132
20143
20152
20162
20173
20181
20194
20201
20211
20222
20233
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting10
Terminated5
Suspended1
Active, not recruiting1
Withdrawn1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)11
University of Michigan5
University of North Carolina, Chapel Hill3
Mallinckrodt2
Northwell Health2
Southeast Renal Research Institute2
University of California, San Francisco2
Aldeyra Therapeutics, Inc.1
All India Institute of Medical Sciences1
Arizona Kidney Disease and Hypertension Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nephrotic Syndrome51
Glomerulosclerosis, Focal Segmental17
Proteinuria16
Kidney Diseases13
Glomerulonephritis, Membranous10
Nephrosis, Lipoid10
Renal Insufficiency, Chronic7
Glomerulonephritis5
Diabetic Nephropathies3
Glomerulonephritis, IGA3

Trials

Showing 51 to 51 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.